Peter has over 13 years experience in patent law together with 14 years molecular biology research experience. He has prepared and prosecuted U.S. and foreign patent applications in a variety of fields including biotechnology (e.g., therapeutics, diagnostics, genomics, vaccines, nucleic acid and protein compositions, liposomal formulations, plant sciences, animal testing systems); medical devices (e.g., closure devices, drug-eluting devices, catheters, stents, guidewires, graft materials); chemical compositions; personal care and hygiene products; anti-aging and cosmetic compositions; herbal supplements; polymeric compositions and films; biofuels; and green technologies employing hydrogen- and solar-based energy sources. He has evaluated patentability of pharmaceutical drug patents; assisted with freedom-to-operate and patentability opinions; formulated freedom-to-operate and invalidity searches; and provided due diligence support and evaluation of various patent portfolios. Peter has also provided pre-litigation and trial support in support of strategy formulation relating to infringement, validity and enforceability issues.
As a former Biotech Patent Examiner with the U.S. Patent and Trademark Office, he examined patent claims directed to therapeutic compositions and methods; in vivo and ex vivo gene therapy, stem cells, viral- and nonviral-based expression vectors, nucleic acid- and protein sequences, diagnostic methods, and transgenic animals, along with extensive commercial and internal database searching and review of prior art.
Articles in the National Law Review database by Peter Brunovskis, Ph.D.